Natasha Holmes
Natasha Holmes
Austin Health, University of Melbourne
Verified email at
Cited by
Cited by
Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations
NE Holmes, JD Turnidge, WJ Munckhof, JO Robinson, TM Korman, ...
Journal of Infectious Diseases 204 (3), 340-347, 2011
Two Novel Point Mutations in Clinical Staphylococcus aureus Reduce Linezolid Susceptibility and Switch on the Stringent Response to Promote Persistent Infection
W Gao, K Chua, JK Davies, HJ Newton, T Seemann, PF Harrison, ...
PLoS pathogens 6 (6), e1000944, 2010
Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia
NE Holmes, JD Turnidge, WJ Munckhof, JO Robinson, TM Korman, ...
Antimicrobial agents and chemotherapy 57 (4), 1654-1663, 2013
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A …
SYC Tong, DC Lye, D Yahav, A Sud, JO Robinson, J Nelson, S Archuleta, ...
Jama 323 (6), 527-537, 2020
Safety and efficacy review of doxycycline
NE Holmes, PGP Charles
Clinical Medicine. Therapeutics 1, CMT. S2035, 2009
Development and validation of a penicillin allergy clinical decision rule
JA Trubiano, S Vogrin, KYL Chua, J Bourke, J Yun, A Douglas, CA Stone, ...
JAMA Internal Medicine 180 (5), 745-752, 2020
Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G2 subclass deficiency
CL Gordon, PDR Johnson, M Permezel, NE Holmes, G Gutteridge, ...
Clinical infectious diseases 50 (5), 672-678, 2010
Relationship between vancomycin-resistant Staphylococcus aureus, vancomycin-intermediate S. aureus, high vancomycin MIC, and outcome in serious S. aureus infections
NE Holmes, PDR Johnson, BP Howden
Journal of clinical microbiology 50 (8), 2548-2552, 2012
Integrated immune dynamics define correlates of COVID-19 severity and antibody responses
M Koutsakos, LC Rowntree, L Hensen, BY Chua, CE Van De Sandt, ...
Cell Reports Medicine 2 (3), 2021
CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity
THO Nguyen, LC Rowntree, J Petersen, BY Chua, L Hensen, L Kedzierski, ...
Immunity 54 (5), 1066-1082. e5, 2021
Treatment of methicillin-resistant Staphylococcus aureus: vancomycin and beyond
NE Holmes, SYC Tong, JS Davis, SJ van Hal
Seminars in respiratory and critical care medicine 36 (01), 017-030, 2015
The penicillin allergy delabeling program: a multicenter whole-of-hospital health services intervention and comparative effectiveness study
KYL Chua, S Vogrin, S Bury, A Douglas, NE Holmes, N Tan, NK Brusco, ...
Clinical infectious diseases 73 (3), 487-496, 2021
Vancomycin therapeutics and monitoring: a contemporary approach
ML Avent, VL Vaska, BA Rogers, AC Cheng, SJ Van Hal, NE Holmes, ...
Internal medicine journal 43 (2), 110-119, 2013
Duration of Respiratory and Gastrointestinal Viral Shedding in Children With SARS-CoV-2: A Systematic Review and Synthesis of Data
CLH Xu, M Raval, JA Schnall, JC Kwong, NE Holmes
The Pediatric Infectious Disease Journal 39 (9), e249-e256, 2020
The Safety and Efficacy of an Oral Penicillin Challenge Program in Cancer Patients: A Multicenter Pilot Study
JA Trubiano, O Smibert, A Douglas, M Devchand, B Lambros, NE Holmes, ...
Open forum infectious diseases 5 (12), ofy306, 2018
What's new in the treatment of serious MRSA infection?
NE Holmes, BP Howden
Current opinion in infectious diseases 27 (6), 471-478, 2014
Genetic and molecular predictors of high vancomycin MIC in Staphylococcus aureus bacteremia isolates
NE Holmes, JD Turnidge, WJ Munckhof, JO Robinson, TM Korman, ...
Journal of clinical microbiology 52 (9), 3384-3393, 2014
Genomic exploration of sequential clinical isolates reveals a distinctive molecular signature of persistent Staphylococcus aureus bacteraemia
SG Giulieri, SL Baines, R Guerillot, T Seemann, A Gonçalves da Silva, ...
Genome medicine 10 (1), 1-17, 2018
Australasian Society for Infectious Diseases Clinical Research Network. Effect of vancomycin or daptomycin with vs without an antistaphylococcal β-lactam on mortality …
SYC Tong, DC Lye, D Yahav, A Sud, JO Robinson, J Nelson, S Archuleta, ...
JAMA 323 (6), 527-537, 2020
Analysis of a Novel pncA Mutation for Susceptibility to Pyrazinamide Therapy
M Karmakar, M Globan, JAM Fyfe, TP Stinear, PDR Johnson, NE Holmes, ...
American journal of respiratory and critical care medicine 198 (4), 541-544, 2018
The system can't perform the operation now. Try again later.
Articles 1–20